Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide for Myoclonic Seizures in Idiopathic Generalised Epilepsy
NCT00693017Phase 3Terminated
- Sponsor
- Eisai Co., Ltd.
- Start
- Jun 2008
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of zonisamide in idiopathic generalized epilepsy (IGE), sponsored by Eisai Co., Ltd.. Started Jun 2008; status: terminated.
02
Drugs
zonisamide
03
Conditions
idiopathic generalized epilepsy (IGE)
Beyond the preview
Go deeper on NCT00693017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00693017.